# Chronicle Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/chronicle-labs-2

- Industry: Software
- Headquarters: San Francisco, US
- Website: chronicle-labs.com
- Latest round: Seed (May 8, 2026)
- Investors on record: 2

## About

Chronicle Labs develops a platform designed for testing and validating AI agents, enhancing their deployment through realistic staging environments built from production data.Chronicle Labs specializes in AI agent testing and validation. Founded in 2026, the company is headquartered in San Francisco, US. It has executed a single deal since its inception, with the most recent deal occurring on May 8, 2026. The founder's history is not publicly available, and there is no mention of the company being a subsidiary or a spin-off from another entity.Chronicle Labs offers an AI Agent Testing and Validation Platform that improves AI agent deployment by utilizing production data to create realistic staging environments. This platform transforms existing business workflows, policies, and edge cases into detailed test scenarios, which are replayed to evaluate AI agents' readiness for production. Clients benefit from increased coverage of production-derived scenarios, reduced critical failures, and enhanced workflow mapping efficiency. The solution primarily serves businesses aiming to optimize AI implementations, with clients from North America and Europe, including Remedy Meds, praising its efficacy in mitigating negative customer experiences.Chronicle Labs generates revenue through a subscription-based model, granting clients access to its AI testing and validation tools. This structure fosters ongoing partnerships, allowing businesses to continually refine their AI agents based on real-time data and testing outcomes. The flagship offerings include features for detailed performance analysis of AI agents and simplified workflow mapping, though specific pricing plans are not disclosed. The focus is on enabling clients to ensure that their AI agents function correctly and align with real-world operational conditions before deployment.In May 2026, Chronicle Labs secured Seed funding from Pioneer Fund and Y Combinator, with plans to use the resources to accelerate its growth. The company aims to introduce new products and expand its market presence in North America and Europe, focusing on enhancing its service offerings. Specific timelines for product launches or market entry have not been disclosed.

## Funding rounds

- Seed, May 8, 2026 — Y Combinator, Pioneer Fund

## Investors

- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Seed
- Pioneer Fund (https://capitalatlas.ai/funds/pioneer-fund) — Seed
